Literature DB >> 17096365

Genotype-phenotype correlations in hereditary familial retinoblastoma.

Melissa Taylor1, Catherine Dehainault, Laurence Desjardins, François Doz, Christine Levy, Xavier Sastre, Jérôme Couturier, Dominique Stoppa-Lyonnet, Claude Houdayer, Marion Gauthier-Villars.   

Abstract

We studied 50 unrelated pedigrees with a family history of retinoblastoma (Rb) (165 carriers of a RB1 mutation) to delineate the spectrum of RB1 germline mutations in familial Rb and to identify genotype-phenotype correlations as well as putative modifiers. Patients were followed at Institut Curie and they were examined by an ophthalmologist, a pediatrician, and a geneticist. All cases of familial Rb were determined via genetic counseling. Clinical features included disease status, laterality, age at diagnosis, mutation type, follow-up, and disease-eye ratio (DER). To eliminate mosaic cases, first-generation carriers displaying low-penetrance (LP) Rb were excluded from the analysis. Complete penetrance was the rule for nonsense and frameshift mutations (25 families) and high penetrance was observed for large rearrangements (eight families). Promoter (two families) and missense (two families) mutations displayed heterogeneous phenotypes and LP. Variable penetrance was observed for splice abnormalities (13 families) and was explained by in/out of frame mutations or respect of functional domains. Surprisingly, two families with the LP g.45867G>T/IVS6+1G>T mutation presented data that conflicted with the data reported in previous publications, as unaffected carriers had paternally inherited mutant alleles. Moreover, RNA analyses suggested that the lack of penetrance in unaffected carriers could be explained by an increase in expression levels of the wild-type allele. This observation prompted us to define a new class "3" of LP alleles. We believe this is the first large-scale study of familial Rb with a high level of homogeneity in the clinical and genetic analysis of patients and their relatives, thereby allowing for reliable intrafamilial genotype-phenotype correlations. Our analysis suggests in some cases the influence of modifier factors probably involved in mRNA level regulation and/or pRB pathway regulation. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17096365     DOI: 10.1002/humu.20443

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  24 in total

1.  Clinical utility gene card for: retinoblastoma.

Authors:  Dietmar Lohmann; Brenda Gallie; Charlotte Dommering; Marion Gauthier-Villars
Journal:  Eur J Hum Genet       Date:  2010-12-08       Impact factor: 4.246

2.  Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.

Authors:  Flore Salviat; Marion Gauthier-Villars; Matthieu Carton; Nathalie Cassoux; Livia Lumbroso-Le Rouic; Catherine Dehainault; Christine Levy; Lisa Golmard; Isabelle Aerts; François Doz; Fidéline Bonnet-Serrano; Stéphanie Hayek; Alexia Savignoni; Dominique Stoppa-Lyonnet; Claude Houdayer
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

3.  Splicing aberrations caused by constitutional RB1 gene mutations in retinoblastoma.

Authors:  Vidya Latha Parsam; Mohammed Javed Ali; Santosh G Honavar; Geeta K Vemuganti; Chitra Kannabiran
Journal:  J Biosci       Date:  2011-06       Impact factor: 1.826

4.  Mutational analysis of the RB1 gene and the inheritance patterns of retinoblastoma in Jordan.

Authors:  Yacoub A Yousef; Abdelghani Tbakhi; Maysa Al-Hussaini; Ibrahim AlNawaiseh; Ala Saab; Amal Afifi; Maysa Naji; Mona Mohammad; Rasha Deebajah; Imad Jaradat; Iyad Sultan; Mustafa Mehyar
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

5.  Genetic screening in Iranian patients with retinoblastoma.

Authors:  K Shahraki; A Ahani; P Sharma; M Faranoush; G Bahoush; I Torktaz; W A Gahl; M Naseripour; B Behnam
Journal:  Eye (Lond)       Date:  2016-12-16       Impact factor: 3.775

Review 6.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

7.  Fine mapping of whole RB1 gene deletions in retinoblastoma patients confirms PCDH8 as a candidate gene for psychomotor delay.

Authors:  Laurent Castéra; Catherine Dehainault; Dorothée Michaux; Livia Lumbroso-Le Rouic; Isabelle Aerts; Francois Doz; Anna Pelet; Jérôme Couturier; Dominique Stoppa-Lyonnet; Marion Gauthier-Villars; Claude Houdayer
Journal:  Eur J Hum Genet       Date:  2012-08-22       Impact factor: 4.246

8.  Low-penetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras.

Authors:  Yoonsoo Park; Akihito Kubo; Takefumi Komiya; Amy Coxon; Kristin Beebe; Len Neckers; Paul S Meltzer; Frederic J Kaye
Journal:  Cell Cycle       Date:  2008-05-30       Impact factor: 4.534

Review 9.  Long non-coding RNAs: emerging players in gastric cancer.

Authors:  Xiaoqiang Guo; Jiazeng Xia; Kaiyuan Deng
Journal:  Tumour Biol       Date:  2014-09-01

10.  RB1 gene mutations in retinoblastoma and its clinical correlation.

Authors:  Mohammad Javed Ali; Vidya Latha Parsam; Santosh G Honavar; Chitra Kannabiran; Geeta K Vemuganti; Vijay Anand P Reddy
Journal:  Saudi J Ophthalmol       Date:  2010-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.